BG107908A - Инхибитори на фарнезилтрансфераза - Google Patents
Инхибитори на фарнезилтрансфераза Download PDFInfo
- Publication number
- BG107908A BG107908A BG107908A BG10790803A BG107908A BG 107908 A BG107908 A BG 107908A BG 107908 A BG107908 A BG 107908A BG 10790803 A BG10790803 A BG 10790803A BG 107908 A BG107908 A BG 107908A
- Authority
- BG
- Bulgaria
- Prior art keywords
- methyl
- imidazol
- cyanophenyl
- biphenyl
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72723000A | 2000-11-30 | 2000-11-30 | |
| US09/912,677 US20020115640A1 (en) | 2000-11-30 | 2001-07-25 | Farnesyltransferase inhibitors |
| PCT/US2001/043168 WO2002074747A1 (en) | 2000-11-30 | 2001-11-30 | Farnesyltransferase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG107908A true BG107908A (bg) | 2004-01-30 |
Family
ID=24921844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG107908A BG107908A (bg) | 2000-11-30 | 2003-06-13 | Инхибитори на фарнезилтрансфераза |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20020115640A1 (es) |
| EP (1) | EP1339695B1 (es) |
| JP (1) | JP2004519503A (es) |
| KR (1) | KR20030060968A (es) |
| CN (1) | CN1487924A (es) |
| AR (1) | AR035375A1 (es) |
| AT (1) | ATE323681T1 (es) |
| BG (1) | BG107908A (es) |
| BR (1) | BR0112028A (es) |
| CA (1) | CA2430619A1 (es) |
| CY (1) | CY1106104T1 (es) |
| CZ (1) | CZ20031804A3 (es) |
| DE (1) | DE60118955T2 (es) |
| DK (1) | DK1339695T3 (es) |
| EC (1) | ECSP034634A (es) |
| ES (1) | ES2261340T3 (es) |
| HK (1) | HK1059260A1 (es) |
| HU (1) | HUP0600331A2 (es) |
| IL (2) | IL156212A0 (es) |
| MX (1) | MXPA03004879A (es) |
| MY (1) | MY136181A (es) |
| NO (1) | NO20032471L (es) |
| NZ (1) | NZ526313A (es) |
| PE (1) | PE20020687A1 (es) |
| PL (1) | PL363637A1 (es) |
| PT (1) | PT1339695E (es) |
| SA (1) | SA01220565B1 (es) |
| SI (1) | SI1339695T1 (es) |
| SK (1) | SK286686B6 (es) |
| UY (1) | UY27046A1 (es) |
| WO (1) | WO2002074747A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006116716A2 (en) * | 2005-04-27 | 2006-11-02 | University Of Florida | Materials and methods for enhanced degradation of mutant proteins associated with human disease |
| JP4592548B2 (ja) * | 2005-08-24 | 2010-12-01 | 株式会社エヌ・ティ・ティ・ドコモ | 送信電力制御方法及び移動通信システム |
| US7722316B2 (en) * | 2005-09-13 | 2010-05-25 | Rolls-Royce Power Engineering Plc | Acoustic viscous damper for centrifugal gas compressor |
| US7790770B2 (en) | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| TW200806284A (en) * | 2006-03-31 | 2008-02-01 | Alcon Mfg Ltd | Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma |
| US8084477B2 (en) * | 2007-10-31 | 2011-12-27 | Bristol-Myers Squibb Company | Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| EP2315751A1 (en) * | 2008-06-26 | 2011-05-04 | Amgen Inc. | Alkynyl alcohols as kinase inhibitors |
| US20130324521A1 (en) * | 2010-11-26 | 2013-12-05 | Reza Ghotbi | Implant for treating or preventing an aneurysm |
| CN105693617B (zh) * | 2014-11-24 | 2018-06-08 | 中国科学院大连化学物理研究所 | 一种tmsn3参与的还原环化反应制备4-咪唑甲醛衍生物的方法 |
| WO2017062552A1 (en) | 2015-10-07 | 2017-04-13 | Tc1 Llc | Resonant power transfer systems having efficiency optimization based on receiver impedance |
| CN112851508A (zh) * | 2019-11-27 | 2021-05-28 | 广东东阳光药业有限公司 | 一种巴洛沙韦中间体的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997036901A1 (en) * | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US6297239B1 (en) * | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| EP1107962B1 (en) * | 1998-08-27 | 2005-02-23 | Pfizer Products Inc. | Quinolin-2-one derivatives useful as anticancer agents |
-
2001
- 2001-07-25 US US09/912,677 patent/US20020115640A1/en not_active Abandoned
- 2001-10-24 MY MYPI20014939A patent/MY136181A/en unknown
- 2001-11-29 UY UY27046A patent/UY27046A1/es not_active Application Discontinuation
- 2001-11-29 PE PE2001001198A patent/PE20020687A1/es not_active Application Discontinuation
- 2001-11-29 AR ARP010105568A patent/AR035375A1/es unknown
- 2001-11-30 DK DK01273519T patent/DK1339695T3/da active
- 2001-11-30 NZ NZ526313A patent/NZ526313A/en unknown
- 2001-11-30 ES ES01273519T patent/ES2261340T3/es not_active Expired - Lifetime
- 2001-11-30 MX MXPA03004879A patent/MXPA03004879A/es active IP Right Grant
- 2001-11-30 PL PL01363637A patent/PL363637A1/xx not_active Application Discontinuation
- 2001-11-30 KR KR10-2003-7007345A patent/KR20030060968A/ko not_active Application Discontinuation
- 2001-11-30 CN CNA018223427A patent/CN1487924A/zh active Pending
- 2001-11-30 JP JP2002573756A patent/JP2004519503A/ja active Pending
- 2001-11-30 EP EP01273519A patent/EP1339695B1/en not_active Expired - Lifetime
- 2001-11-30 HU HU0600331A patent/HUP0600331A2/hu unknown
- 2001-11-30 PT PT01273519T patent/PT1339695E/pt unknown
- 2001-11-30 AT AT01273519T patent/ATE323681T1/de not_active IP Right Cessation
- 2001-11-30 WO PCT/US2001/043168 patent/WO2002074747A1/en active IP Right Grant
- 2001-11-30 CZ CZ20031804A patent/CZ20031804A3/cs unknown
- 2001-11-30 SK SK823-2003A patent/SK286686B6/sk not_active IP Right Cessation
- 2001-11-30 BR BR0112028-0A patent/BR0112028A/pt not_active IP Right Cessation
- 2001-11-30 SI SI200130573T patent/SI1339695T1/sl unknown
- 2001-11-30 DE DE60118955T patent/DE60118955T2/de not_active Expired - Fee Related
- 2001-11-30 IL IL15621201A patent/IL156212A0/xx active IP Right Grant
- 2001-11-30 CA CA002430619A patent/CA2430619A1/en not_active Abandoned
- 2001-12-02 SA SA01220565A patent/SA01220565B1/ar unknown
-
2003
- 2003-05-29 IL IL156212A patent/IL156212A/en not_active IP Right Cessation
- 2003-05-30 EC EC2003004634A patent/ECSP034634A/es unknown
- 2003-05-30 NO NO20032471A patent/NO20032471L/no not_active Application Discontinuation
- 2003-06-13 BG BG107908A patent/BG107908A/bg unknown
-
2004
- 2004-01-27 HK HK04100551A patent/HK1059260A1/xx not_active IP Right Cessation
-
2006
- 2006-06-23 CY CY20061100852T patent/CY1106104T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3207901B2 (ja) | レトロウイルス阻害性化合物 | |
| US8598168B2 (en) | Inhibitors of histone deacetylase | |
| CN101184734B (zh) | 治疗细胞增殖紊乱的化合物和方法 | |
| JP5001505B2 (ja) | 新規チオウレア誘導体およびこれを含有する薬学的組成物 | |
| KR100893804B1 (ko) | 히스톤 데아세틸라아제의 억제제 | |
| JP3827324B2 (ja) | 金属タンパク質分解酵素阻害剤 | |
| US7323570B2 (en) | Farnesyltransferase inhibitors | |
| KR20100107509A (ko) | 히스톤 데아세틸라아제의 억제제 | |
| JP2006503019A (ja) | メタロプロテイナーゼｍｍｐ１２のインヒビターとしての２，５−ジオキソイミダゾリジン−４−イルアセトアミドおよび類似体 | |
| CA2548849A1 (en) | Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease | |
| SK48499A3 (en) | Heteroaryl succinamides and their use as metalloproteinase inhibitors | |
| SK25199A3 (en) | Heterocyclic metalloprotease inhibitors | |
| BG103433A (bg) | Бензамидоалдехиди и тяхното използване като инхибитори на цистеинпротеаза | |
| EA039144B1 (ru) | Новые гетероариламидные производные как селективные ингибиторы гистондеацетилаз 1 и/или 2 (hdac1-2) | |
| BG107908A (bg) | Инхибитори на фарнезилтрансфераза | |
| US6812237B2 (en) | N-substituted peptidyl nitriles as cysteine cathepsin inhibitors | |
| WO2000007985A1 (fr) | Nouveaux derives d'uree renfermant des heterocycles aromatiques azotes | |
| JP2002212179A (ja) | 新規アニリド誘導体又はその塩及びこれを含有する医薬 | |
| EP1283825B1 (en) | N-substituted peptidyl nitriles as cysteine cathepsin inhibitors | |
| JPH0558997A (ja) | チオカルバモイルアセトニトリル誘導体 | |
| AU2001297704B2 (en) | Farnesyltransferase inhibitors | |
| JP2024500427A (ja) | Ｅｒａｐ阻害剤 | |
| SK283634B6 (sk) | Butadiénový, aminobutadiénový a pyrolidínový derivát a spôsoby ich prípravy | |
| AU2001297704A1 (en) | Farnesyltransferase inhibitors | |
| JPH05194429A (ja) | アゾール化合物、その製造法および用途 |